TerminatedNot Applicable

Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery

Stopped: Management Decision

United States30 participantsStarted 2009-09

Plain-language summary

The purpose of this study is to examine AWBAT™-D compared to Mepilex® Ag for the treatment of donor sites in burn surgery.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Burn wounds requiring skin grafting * Matched donor sites available * 1-30% TBSA Exclusion Criteria: * Severe inhalation injury * Pregnancy * Co-morbidity which may compromise healing * Known allergy to pork or pork products

What they're measuring

Compare rate of healing of donor sites

Timeframe: 6 month follow-up

Trial details

NCT IDNCT00974597

SponsorAubrey Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-09

View on ClinicalTrials.gov More Burn Surgery trials